A Study Comparing the Efficacy and Safety of HRS9531 Injection With Semaglutide Injection in Subjects With Obesity
Clinical trial NCT07285902 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07285902
- Sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-25
- Primary completion
- 2027-03-01
- Enrollment
- 572
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.